suramin has been researched along with carboplatin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bostick-Bruton, F; Cooper, MR; LaRocca, RV; Myers, CE; Reed, E | 1 |
| Kaufmann, SH; Rowinsky, EK | 1 |
| Emanuele, S; Giuliano, M; Lauricella, M; Tesoriere, G; Vento, R | 1 |
| Au, JL; Chen, D; DeHoff, C; Fischer, B; Grever, M; Kanter, S; Murgo, AJ; Otterson, GA; Song, S; Villalona-Calero, MA; Wientjes, MG; Yeh, TK; Young, D | 1 |
| Au, JL; Lu, Z; Wientjes, TS | 1 |
| Au, JL; Chen, D; Grever, M; Jensen, R; Murgo, AJ; Otterson, GA; Song, SH; Villalona-Calero, M; Wientjes, MG; Yeh, TK; Zhao, L | 1 |
| Au, JL; Bekaii-Saab, T; Eng, C; Grever, M; Jensen, R; Murgo, AJ; Otterson, GA; Villalona-Calero, MA; Weber, F; Wei, Y; Wientjes, MG; Yeh, TK; Young, D; Zhang, Y | 1 |
1 review(s) available for suramin and carboplatin
| Article | Year |
|---|---|
Topotecan in combination chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Paclitaxel; Suramin; Topoisomerase I Inhibitors; Topotecan | 1997 |
3 trial(s) available for suramin and carboplatin
| Article | Year |
|---|---|
Suramin in advanced platinum-resistant ovarian cancer.
Topics: Adult; Aged; Carboplatin; Cisplatin; Drug Evaluation; Drug Resistance; Female; Humans; Middle Aged; Ovarian Neoplasms; Suramin | 1992 |
Phase I study of low-dose suramin as a chemosensitizer in patients with advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Agents; Area Under Curve; Carboplatin; Carcinoma, Non-Small-Cell Lung; Drug Interactions; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Paclitaxel; Suramin; Time Factors | 2003 |
Noncytotoxic suramin as a chemosensitizer in patients with advanced non-small-cell lung cancer: a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Drug Resistance, Neoplasm; Drug Synergism; Female; Fibroblast Growth Factor 1; Fibroblast Growth Factor 2; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Suramin | 2008 |
3 other study(ies) available for suramin and carboplatin
| Article | Year |
|---|---|
Apoptotic effects of different drugs on cultured retinoblastoma Y79 cells.
Topics: Amsacrine; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Butyrates; Butyric Acid; Camptothecin; Carboplatin; Cisplatin; DNA Damage; Drug Screening Assays, Antitumor; Etoposide; Humans; Paclitaxel; Retinoblastoma; Suramin; Tumor Cells, Cultured | 1998 |
Nontoxic suramin treatments enhance docetaxel activity in chemotherapy-pretreated non-small cell lung xenograft tumors.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bromodeoxyuridine; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Docetaxel; Drug Synergism; Humans; Lung Neoplasms; Male; Mice; Mice, Nude; Paclitaxel; Suramin; Taxoids; Tumor Burden; Xenograft Model Antitumor Assays | 2005 |
Nontoxic suramin as a chemosensitizer in patients: dosing nomogram development.
Topics: Algorithms; Antineoplastic Agents; Blood Proteins; Carboplatin; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Models, Biological; Nomograms; Paclitaxel; Protein Binding; Reproducibility of Results; Suramin | 2006 |